Takayoshi Hirota

1.1k citations

54 papers · 858 indexed · h-index 16

Cardiology and Cardiovascular Medicine top 5%
- Cardiomyopathy and Myosin Studies 34
- Cardiovascular Effects of Exercise 14
- Cardiovascular Function and Risk Factors 12
- Viral Infections and Immunology Research 12
- Cardiac Arrhythmias and Treatments 5
Developmental Neuroscience top 10%
Nephrology top 10%
Epidemiology
- Trypanosoma species research and implications 10
Rheumatology
Molecular Biology
- Amyloidosis: Diagnosis, Treatment, Outcomes 11
Physiology
- Sarcoidosis and Beryllium Toxicity Research 5

Co-authors: Hiroaki Kitaoka Toru Kubo Naohito Yamasaki Yoshinori Doi Yuichi Baba Yoshihisa Matsumura Makoto Okawa Kayo Hayato
Cited by: Cardiology and Cardiovascular Medicine Developmental Neuroscience Nephrology
Partner nations: Japan United States

In The Last Decade

Takayoshi Hirota

50 papers receiving 849 citations

Peers

Countries citing papers authored by Takayoshi Hirota

Since Specialization

Citations

This map shows the geographic impact of Takayoshi Hirota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takayoshi Hirota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takayoshi Hirota more than expected).

Fields of papers citing papers by Takayoshi Hirota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takayoshi Hirota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takayoshi Hirota. The network helps show where Takayoshi Hirota may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Takayoshi Hirota, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Takayoshi Hirota Line = papers co-authored together Takayoshi Hirota links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Importance of Fourth Heart Sound and Preserved Left Atrial Function in Wild-Type Transthyretin Amyloidosis Yuri Ochi,Naohito Yamasaki,Toru Kubo,Yuichi Baba,Kazuya Miyagawa,Tatsuya Noguchi,Takayoshi Hirota,Tomoyuki Hamada,Hiroaki Kitaoka	2024	3
2	High-sensitivity Cardiac Troponin T Is a Useful Biomarker for Predicting the Prognosis of Patients with Systemic Sarcoidosis Regardless of Cardiac Involvement Yuichi Baba,Toru Kubo,Yuri Ochi,Takayoshi Hirota,Naohito Yamasaki,Hiroshi Ohnishi,Tetsuya Kubota,Akihito Yokoyama,Hiroaki Kitaoka	2023	2
3	Associations between electrocardiographic findings and echocardiographic profiles in patients with hypertrophic cardiomyopathy Tomomi Matsuo,Yuri Ochi,Toru Kubo,Yuichi Baba,Kazuya Miyagawa,Tatsuya Noguchi,Takayoshi Hirota,Tomoyuki Hamada,Naohito Yamasaki,Hiroaki Kitaoka	2023	0
4	A Drifting Dislodged Leadless Pacemaker in the Bilateral Pulmonary Arteries Kenta Sugiura,Yuichi Baba,Takayoshi Hirota,Toru Kubo,Hiroaki Kitaoka	2022	3
5	A Case Report of Asymmetry of Systolic Anterior Motion of the Mitral Valve, a Not Widely Well-Known but Practically Important Echocardiographic Presentation in Hypertrophic Cardiomyopathy Yuri Ochi,Toru Kubo,Yuichi Baba,Motoko Ueda,Takayoshi Hirota,Naohito Yamasaki,Hiroaki Kitaoka	2021	1
6	Cardiac manifestations and effects of enzyme replacement therapy for over 10 years in adults with the attenuated form of mucopolysaccharidosis type I Kenta Sugiura,Toru Kubo,Yuri Ochi,Yuichi Baba,Takayoshi Hirota,Naohito Yamasaki,Hiroaki Kitaoka	2020	6
7	A single atrial septal defect masquerading as multiple defects due to a refraction artifact – A cautionary note Yuri Ochi,Naohito Yamasaki,Yuichi Baba,Juri Kawaguchi,Yasuteru Nakashima,Motoko Ueta,Takayoshi Hirota,Toru Kubo,Hiroaki Kitaoka	2020	1
8	Elevation of High-Sensitivity Cardiac Troponin T and Left Ventricular Remodelling in Hypertrophic Cardiomyopathy Toru Kubo,Yuri Ochi,Yuichi Baba,Kenta Sugiura,A Takahashi,Takayoshi Hirota,Shigeo Yamanaka,Naohito Yamasaki,Yoshinori Doi,Hiroaki Kitaoka	2020	15
9	Validation of the Kumamoto criteria for prediction of 99m technetium pyrophosphate scintigraphy positivity as a strategy for diagnosis of transthyretin cardiac amyloidosis: A retrospective cohort study in Kochi Yuri Ochi,Toru Kubo,Yuichi Baba,Motoko Ueda,Kazuya Miyagawa,Tatsuya Noguchi,Takayoshi Hirota,Naohito Yamasaki,Hiroaki Kitaoka	2020	9
10	A case report of an uncommon presentation of 99mtechnetium pyrophosphate scintigraphy in transthyretin cardiac amyloidosis: A potential diagnostic pitfall, pseudo-positive or pseudo-negative? Yuri Ochi,Toru Kubo,Yasuteru Nakashima,A Takahashi,Yuichi Baba,Takayoshi Hirota,Naohito Yamasaki,Hiroaki Kitaoka	2019	6
11	Integrated diagnostic approach to wild-type transthyretin cardiac amyloidosis with the use of high-sensitivity cardiac troponin T measurement and 99mTc-pyrophosphate scintigraphy Yuri Ochi,Toru Kubo,Yasuteru Nakashima,Yuichi Baba,Takayoshi Hirota,Naohito Yamasaki,Taro Yamashita,Mitsuharu Ueda,Yukio Ando,Hiroaki Kitaoka	2019	15
12	Reconsideration of the cut-off value of angiotensin-converting enzyme for screening of sarcoidosis in Japanese patients Yuichi Baba,Toru Kubo,Shigeo Yamanaka,Yuri Ochi,Takayoshi Hirota,Naohito Yamasaki,Hiroshi Ohnishi,Tetsuya Kubota,Akihito Yokoyama,Hiroaki Kitaoka	2019	11
13	Abstract 12143: A Validation Study of Phenotype-guided Genetic Testing Using the Mayo HCM Genotype Predictor Score for Japanese Patients With Hypertrophic Cardiomyopathy Toshihiro Moriki,Toru Kubo,Yuri Ochi,A Takahashi,Takayoshi Hirota,Naohito Yamasaki,Hiroaki Kitaoka	2017	1
14	An Abnormal Serum Concentration of High-sensitivity Cardiac Troponin T is Associated with Progression of Left Ventricular Remodeling in Hypertrophic Cardiomyopathy Toru Kubo,Takayoshi Hirota,Tomoyuki Hamada,Tatsuya Noguchi,Katsutoshi Tanioka,Yamasaki Naohito,Sugiura Tetsuro,Hiroaki Kitaoka	2016	5
15	Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy Toru Kubo,Yuri Ochi,Yuichi Baba,Takayoshi Hirota,Katsutoshi Tanioka,Naohito Yamasaki,Makoto Yoshimitsu,Koji Higuchi,Toshihiro Takenaka,Kimiko Nakajima,Tadayasu Togawa,Takahiro Tsukimura,Shigetoshi Sano,Chuwa Tei,Hitoshi Sakuraba,Hiroaki Kitaoka	2016	27
16	Erythrocyte creatine as a marker of intravascular hemolysis due to left ventricular outflow tract obstruction in hypertrophic cardiomyopathy Toru Kubo,Toshika Okumiya,Yuichi Baba,Takayoshi Hirota,Katsutoshi Tanioka,Naohito Yamasaki,Tetsuro Sugiura,Yoshinori Doi,Hiroaki Kitaoka	2015	11
17	Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy Toru Kubo,Hiroaki Kitaoka,Shigeo Yamanaka,Takayoshi Hirota,Yuichi Baba,Kayo Hayashi,Tatsuo Iiyama,Naoko Kumagai,Katsutoshi Tanioka,Naohito Yamasaki,Yoshihisa Matsumura,Takashi Furuno,Tetsuro Sugiura,Yoshinori Doi	2013	114
18	A frameshift deletion mutation in the cardiac myosin-binding protein C gene associated with dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy Nobuhiko Hitomi,Toru Kubo,Hiroaki Kitaoka,Takayoshi Hirota,Tomoyuki Hamada,Eri Hoshikawa,Kayo Hayato,Makoto Okawa,Akinori Kimura,Yoshinori L. Doi	2010	13
19	Utility of tissue Doppler imaging to predict exercise capacity in hypertrophic cardiomyopathy: Comparison with B-type natriuretic peptide Hiroaki Kitaoka,Toru Kubo,Makoto Okawa,Takayoshi Hirota,Kayo Hayato,Naohito Yamasaki,Yoshihisa Matsumura,Yoshinori Doi	2009	16
20	Improvement in prognosis of dilated cardiomyopathy in the elderly over the past 20 years Toru Kubo,Yoshihisa Matsumura,Hiroaki Kitaoka,Makoto Okawa,Takayoshi Hirota,Tomoyuki Hamada,Nobuhiko Hitomi,Eri Hoshikawa,Kayo Hayato,Yūji Shimizu,Naohito Yamasaki,Toshikazu Yabe,Masanori Nishinaga,Jun Takata,Yoshinori Doi	2008	20

About Takayoshi Hirota

Takayoshi Hirota is a scholar working on Cardiology and Cardiovascular Medicine, Developmental Neuroscience and Nephrology, having authored 54 papers that have together received 858 indexed citations. Recurring topics across this work include Cardiomyopathy and Myosin Studies (34 papers), Cardiovascular Effects of Exercise (14 papers), Cardiovascular Function and Risk Factors (12 papers), Viral Infections and Immunology Research (12 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (11 papers), Trypanosoma species research and implications (10 papers), Cardiac Arrhythmias and Treatments (5 papers) and Sarcoidosis and Beryllium Toxicity Research (5 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (687 citations), Developmental Neuroscience (44 citations) and Nephrology (44 citations). Takayoshi Hirota has collaborated with scholars based in Japan and United States. Frequent co-authors include Hiroaki Kitaoka, Toru Kubo, Naohito Yamasaki, Yoshinori Doi, Yuichi Baba, Yoshihisa Matsumura, Makoto Okawa, Kayo Hayato, Toshikazu Yabe and Shigeo Yamanaka.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact